A 12 mg weekly dose consumes a 30 mg vial in two and a half weeks, which is inside a typical refrigerated beyond-use date for compounded peptides
Current investigations are focused on understanding whether NNMT inhibition might influence cancer progression or aggressiveness
The amount used depends on the drugs guidelines
Schreiber F, Balas I, Robinson MJ, Bakdash G
Clinical manifestations range from asymptomatic elevations in serum transaminases to more severe conditions, including cholestatic jaundice, peliosis hepatis, hepatic adenomas, and, in rare cases, hepatocellular carcinoma (75)
It differs from IGF-1 by additional 13 amino acids at the N-terminus and the substitution of arginine with glutamic acid at the 3rd position